{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:33:07Z","timestamp":1792607587519,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Chronic lung allograft dysfunction significantly impairs long-term lung transplant survival. Bronchiolitis obliterans syndrome is a chronic lung allograft dysfunction phenotype characterized by fibroproliferative changes in noncartilaginous airways. We previously demonstrated that the tyrosine kinase inhibitor nintedanib reduces chronic airway changes in murine tracheal allografts. In this study, we investigated whether delayed treatment, similar to the clinical scenario following lung transplantation, would still be beneficial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Recipient CBA\/JRj mice received orthotopic tracheal transplants from donor C57BL\/6JRj mice. A dosage of 60\u2009mg\/kg of nintedanib was administered orally to transplanted mice every day between days 14 and 29 after transplantation. Histological and immunofluorescence analyses, as well as intragraft gene expression measurements, were performed after 14 and 30 d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Delayed-treated tracheal allografts (nintedanib 14\u201330) exhibited less evidence of chronic rejection than untreated allografts on day 30 (control 30). This is demonstrated by an increased epithelium-to-lamina propria ratio (0.62\u2005\u00b1\u20050.16 [nintedanib 14\u201330] versus 0.50\u2005\u00b1\u20050.01 [control 30];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05), with a reduction in CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell, dendritic cell, and macrophage infiltration. Furthermore, intragraft gene expression of inflammatory cytokines, adhesion molecules, and growth factors was also lowered. While allografts treated immediately (nintedanib 30) demonstrated a comparable epithelium-to-lamina propria ratio to the nintedanib 14\u201330 group, earlier treatment resulted in considerably lower infiltration of CD4\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells as well as alpha smooth muscle actin expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Even delayed nintedanib therapy has an attenuating effect on chronic inflammation but is less effective regarding the fibroproliferative changes that are considered a sign of chronic airway changes after murine tracheal transplantation. Thus, it may serve as supportive therapy in the clinical setting after lung transplantation, but earlier initiation might be more effective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001967","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:00:09Z","timestamp":1782176409000},"page":"e1967","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevent or Treat? Evaluating a Delayed Treatment With Nintedanib After Murine Orthotopic Tracheal Transplantation"],"prefix":"10.1097","volume":"12","author":[{"given":"Julia","family":"Mauer","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Erlangen, Erlangen, Germany."},{"name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Graebner","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Erlangen, Erlangen, Germany."},{"name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Kuckhahn","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Erlangen, Erlangen, Germany."},{"name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0210-4121","authenticated-orcid":false,"given":"Martina","family":"Ramsperger-Gleixner","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Erlangen, Erlangen, Germany."},{"name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weyand","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Erlangen, Erlangen, Germany."},{"name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heim","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, University Hospital Erlangen, Erlangen, Germany."},{"name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Erlangen, Germany."},{"name":"Department of Cardiac and Vascular Surgery, Medical Campus Upper Franconia (MCO), Klinikum Bayreuth, Bayreuth, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"R1-20260623","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.21037\/jtd.2017.11.84","article-title":"History of lung transplantation.","volume":"9","author":"Venuta","year":"2017","journal-title":"J Thorac Dis"},{"key":"R2-20260623","doi-asserted-by":"crossref","first-page":"220060","DOI":"10.1183\/16000617.0060-2022","article-title":"Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle.","volume":"31","author":"Bos","year":"2022","journal-title":"Eur Respir Rev"},{"key":"R3-20260623","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.healun.2022.08.007","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease.","volume":"41","author":"Perch","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R4-20260623","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment\u2014a consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R5-20260623","doi-asserted-by":"crossref","first-page":"412","DOI":"10.21037\/atm.2020.03.20","article-title":"The role of innate immunity in the long-term outcome of lung transplantation.","volume":"8","author":"Kawashima","year":"2020","journal-title":"Ann Transl Med"},{"key":"R6-20260623","doi-asserted-by":"crossref","first-page":"100626","DOI":"10.1016\/j.trre.2021.100626","article-title":"The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.","volume":"35","author":"van der Ploeg","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"R7-20260623","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/TP.0000000000002250","article-title":"Diagnosis, pathophysiology and experimental models of chronic lung allograft rejection.","volume":"102","author":"Gauthier","year":"2018","journal-title":"Transplantation"},{"key":"R8-20260623","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1749-8090-6-92","article-title":"A review of bronchiolitis obliterans syndrome and therapeutic strategies.","volume":"6","author":"Hayes","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"R9-20260623","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.","volume":"349","author":"Wollin","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-20260623","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur Respir J"},{"key":"R13-20260623","doi-asserted-by":"crossref","first-page":"1702593","DOI":"10.1183\/13993003.02593-2017","article-title":"Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis.","volume":"52","author":"Flaherty","year":"2018","journal-title":"Eur Respir J"},{"key":"R14-20260623","first-page":"e54268","article-title":"A comparison of the effectiveness of nintedanib and pirfenidone in treating idiopathic pulmonary fibrosis: a systematic review.","volume":"16","author":"Man","year":"2024","journal-title":"Cureus"},{"key":"R15-20260623","doi-asserted-by":"crossref","first-page":"17534666231165912","DOI":"10.1177\/17534666231165912","article-title":"Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis.","volume":"17","author":"Astor","year":"2023","journal-title":"Ther Adv Respir Dis"},{"key":"R16-20260623","doi-asserted-by":"crossref","first-page":"e00312","DOI":"10.1002\/rcr2.312","article-title":"Safety of nintedanib before lung transplant: an Italian case series.","volume":"6","author":"Balestro","year":"2018","journal-title":"Respirol Case Rep"},{"key":"R17-20260623","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/fcp.12522","article-title":"Restrictive allograft dysfunction after lung transplantation: is there a place for nintedanib?-a case report.","volume":"34","author":"Pluchart","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"R18-20260623","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms19051269","article-title":"VEGF (vascular endothelial growth factor) and fibrotic lung disease.","volume":"19","author":"Barratt","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R19-20260623","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.coph.2008.03.003","article-title":"Vascular endothelial growth factor of the lung: friend or foe.","volume":"8","author":"Tuder","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"R20-20260623","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/09031936.00152106","article-title":"Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.","volume":"29","author":"Chaudhary","year":"2007","journal-title":"Eur Respir J"},{"key":"R21-20260623","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.2102106","article-title":"Growth factor upregulation during obliterative bronchiolitis in the mouse model.","volume":"166","author":"Aris","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-20260623","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1165\/rcmb.2014-0294TR","article-title":"Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies.","volume":"52","author":"Noskovicova","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R23-20260623","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/micr.20329","article-title":"Experimental orthotopic tracheal transplantation: the Stanford technique.","volume":"27","author":"Schrepfer","year":"2007","journal-title":"Microsurgery"},{"key":"R24-20260623","doi-asserted-by":"crossref","first-page":"101608","DOI":"10.1016\/j.trim.2022.101608","article-title":"Nintedanib reduces alloimmune-induced chronic airway changes in murine tracheal allografts.","volume":"73","author":"Mauer","year":"2022","journal-title":"Transpl Immunol"},{"key":"R25-20260623","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/TP.0b013e3181938913","article-title":"Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts.","volume":"87","author":"Abele","year":"2009","journal-title":"Transplantation"},{"key":"R26-20260623","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/TP.0b013e3181e8a699","article-title":"Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft model.","volume":"90","author":"Heim","year":"2010","journal-title":"Transplantation"},{"key":"R27-20260623","first-page":"33","article-title":"The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression.","volume":"14","author":"Overbergh","year":"2003","journal-title":"J Biomol Tech"},{"key":"R28-20260623","doi-asserted-by":"crossref","first-page":"42036","DOI":"10.1074\/jbc.M509600200","article-title":"Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element.","volume":"280","author":"Yamamoto","year":"2005","journal-title":"J Biol Chem"},{"key":"R29-20260623","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1006\/bbrc.2002.6710","article-title":"Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.","volume":"292","author":"Zhang","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R30-20260623","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.174.7.3869","article-title":"Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis.","volume":"174","author":"Murakawa","year":"2005","journal-title":"J Immunol"},{"key":"R31-20260623","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.xjtc.2020.12.011","article-title":"Commentary: antifibrotic medications and wound healing after cardiac surgery.","volume":"6","author":"Balsam","year":"2021","journal-title":"JTCVS Tech"},{"key":"R32-20260623","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1097\/TP.0000000000001592","article-title":"BOS is associated with increased cytotoxic proinflammatory CD8 T, NKT-like, and NK cells in the small airways.","volume":"101","author":"Hodge","year":"2017","journal-title":"Transplantation"},{"key":"R33-20260623","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.healun.2024.06.001","article-title":"The CD8(+) T cell content of transbronchial biopsies from patients with a first episode of clinically stable grade A1 cellular rejection is associated with future chronic lung allograft dysfunction.","volume":"43","author":"Beber","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R34-20260623","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3389\/fimmu.2018.02548","article-title":"T cell allorecognition pathways in solid organ transplantation.","volume":"9","author":"Siu","year":"2018","journal-title":"Front Immunol"},{"key":"R35-20260623","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40472-016-0130-9","article-title":"Macrophages as effectors of acute and chronic allograft injury.","volume":"3","author":"Liu","year":"2016","journal-title":"Curr Transplant Rep"},{"key":"R36-20260623","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated.","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R37-20260623","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis.","volume":"108","author":"Bui","year":"2020","journal-title":"J Leukoc Biol"},{"key":"R38-20260623","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exer.2015.07.009","article-title":"Myofibroblasts.","volume":"142","author":"Hinz","year":"2016","journal-title":"Exp Eye Res"},{"key":"R39-20260623","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","article-title":"Fibroblast and myofibroblast activation in normal tissue repair and fibrosis.","volume":"25","author":"Younesi","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R40-20260623","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12931-024-02898-9","article-title":"Regulation of myofibroblast dedifferentiation in pulmonary fibrosis.","volume":"25","author":"Ju","year":"2024","journal-title":"Respir Res"},{"key":"R41-20260623","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/10409238.2016.1269716","article-title":"Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease.","volume":"52","author":"Gjaltema","year":"2017","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"R42-20260623","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ajpath.2021.05.014","article-title":"Protein signatures of remodeled airways in transplanted lungs with bronchiolitis obliterans syndrome obtained using laser-capture microdissection.","volume":"191","author":"Muller","year":"2021","journal-title":"Am J Pathol"},{"key":"R43-20260623","doi-asserted-by":"crossref","first-page":"e000177","DOI":"10.1136\/bmjresp-2016-000177","article-title":"Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation.","volume":"4","author":"M\u00fcller","year":"2017","journal-title":"BMJ Open Respir Res"},{"key":"R44-20260623","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/abbs\/gmab065","article-title":"Collagen prolyl 4-hydroxylases modify tumor progression.","volume":"53","author":"Shi","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R45-20260623","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12882-024-03733-5","article-title":"P4HB regulates the TGFbeta\/SMAD3 signaling pathway through PRMT1 to participate in high glucose-induced epithelial-mesenchymal transition and fibrosis of renal tubular epithelial cells.","volume":"25","author":"Wang","year":"2024","journal-title":"BMC Nephrol"},{"key":"R46-20260623","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2147\/DDDT.S288369","article-title":"The effect of nintedanib on T-cell activation, subsets and functions.","volume":"15","author":"Ubieta","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"R47-20260623","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40262-019-00766-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of nintedanib.","volume":"58","author":"Wind","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"R48-20260623","doi-asserted-by":"crossref","first-page":"3867198","DOI":"10.1155\/2020\/3867198","article-title":"Effects of nintedanib in an animal model of liver fibrosis.","volume":"2020","author":"Wollin","year":"2020","journal-title":"Biomed Res Int"},{"key":"R49-20260623","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.matbio.2017.11.010","article-title":"Inflammation and fibrosis.","volume":"68\u201369","author":"Mack","year":"2018","journal-title":"Matrix Biol"},{"key":"R50-20260623","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1165\/rcmb.2007-0257RC","article-title":"Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants.","volume":"37","author":"Okazaki","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R51-20260623","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nprot.2008.218","article-title":"Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology.","volume":"4","author":"Krupnick","year":"2009","journal-title":"Nat Protoc"},{"key":"R52-20260623","doi-asserted-by":"crossref","first-page":"00675-2024","DOI":"10.1183\/23120541.00675-2024","article-title":"Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres.","volume":"11","author":"Gottlieb","year":"2025","journal-title":"ERJ Open Res"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000001967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:34:48Z","timestamp":1787747688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001967","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"2025-12-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}